KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Debt Ratio: 2011-2024

Historic Debt Ratio for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Dec 2024 value amounting to 0.03.

  • Supernus Pharmaceuticals' Debt Ratio fell 77.19% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10, marking a year-over-year decrease of 35.23%. This contributed to the annual value of 0.03 for FY2024, which is 15.09% down from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Debt Ratio stood at 0.03 for FY2024, which was down 15.09% from 0.04 recorded in FY2023.
  • Supernus Pharmaceuticals' Debt Ratio's 5-year high stood at 0.25 during FY2021, with a 5-year trough of 0.01 in FY2022.
  • Moreover, its 3-year median value for Debt Ratio was 0.03 (2024), whereas its average is 0.03.
  • Its Debt Ratio has fluctuated over the past 5 years, first spiked by 1,122.11% in 2021, then tumbled by 95.06% in 2022.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Debt Ratio stood at 0.02 in 2020, then surged by 1,122.11% to 0.25 in 2021, then tumbled by 95.06% to 0.01 in 2022, then surged by 228.52% to 0.04 in 2023, then fell by 15.09% to 0.03 in 2024.